Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal Carcinoma

Clinical trial NCT00183794 · COMPLETED

Trial details

NCT number: NCT00183794
Sponsor: University of Southern California
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Carcinoma Peritoneal Neoplasms

Start date: 2002-11-01
Primary completion: 2009-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.